Alvotech ALVO
NASDAQ ALVO
$5.45 -0.17 (-3.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alvotech (ALVO) Accumulated Expenses (2021 - 2023)

Updated

Alvotech (ALVO) posted Accumulated Expenses of $14.52 million for Q2 2023.

Analysis

Alvotech (ALVO) Accumulated Expenses (2021 - 2023) Analysis & Trends

At the end of FY2022, Alvotech's Accumulated Expenses came in at $18.72 million, up 291.2% from FY2021.

  • In prior years, Alvotech's Accumulated Expenses was $4.79 million in FY2021.
  • The Q2 2023 figure stands as the lowest quarterly Accumulated Expenses since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Alvotech 1.75 Bn 1.32 Bn 2.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 14.52 Mn
Dec 31, 2022 18.72 Mn
Dec 31, 2021 4.79 Mn
API Access

Alvotech Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ALVO&period=max&api_key=YOUR_API_KEY